What is the normal size of an intramammary (within the breast) lymph (lymphatic) gland?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Size of Intramammary Lymph Nodes

Normal intramammary lymph nodes typically measure up to 10 mm in long-axis diameter and are considered benign when they demonstrate characteristic morphological features. 1

Characteristics of Normal Intramammary Lymph Nodes

  • Normal intramammary lymph nodes are well-circumscribed, oval or round structures that may be visualized on imaging studies 2, 3
  • They typically demonstrate a fatty hilum, lobular or oval shape, and circumscribed margins without evidence of central necrosis, cortical thickening, or loss of fatty hilum 1
  • On ultrasound, normal intramammary lymph nodes appear as well-defined echo-poor masses with echogenic centers 4
  • They are most commonly located in the upper outer quadrant of the breast 2, 5

Size Parameters for Normal vs. Abnormal Intramammary Lymph Nodes

  • Intramammary lymph nodes measuring up to 10 mm in long-axis diameter are commonly seen on high-risk screening breast MRI examinations in patients without breast cancer and are considered benign 1
  • In patients with newly diagnosed breast cancer, the American Joint Committee on Cancer suggests a long-axis measurement of ≥ 5 mm as a guideline to differentiate benign versus potentially malignant intramammary lymph nodes 1
  • Nodes that are 1 cm or larger in diameter without a lucent center or hilar notch should raise suspicion for malignancy 3

Morphological Features That May Indicate Abnormality

  • Loss of fatty hilum, irregular shape, and rounded appearance (which can be quantified by a short-axis/long-axis length ratio greater than 0.5) raises suspicion for metastatic disease 1
  • Metastatic intramammary lymph nodes typically appear enlarged (≥1 cm), homogeneous, and well-circumscribed without the lucent center or hilar notch characteristic of benign nodes 3
  • Development of malignant microcalcifications within an intramammary lymph node may indicate metastatic involvement 2

Clinical Significance

  • Intramammary lymph node involvement in breast cancer can alter clinical staging and treatment planning 1
  • The American Joint Committee on Cancer recommends that positive intramammary lymph nodes should be counted as positive lymph nodes in the N staging 6
  • Metastatic disease to intramammary lymph nodes may be the first clinical and/or radiographic sign of breast cancer 2, 3

Imaging Modalities for Assessment

  • MRI and PET-CT demonstrate the highest sensitivities for detecting abnormal intramammary lymph nodes 1
  • Ultrasound is helpful for staging, and ultrasound-guided fine-needle aspiration can be performed in cases of suspected metastasis 1
  • On mammography, suspicious nodes appear as well-circumscribed, homogeneous, oval or round opacities, typically larger than 1 cm 2

References

Research

Imaging and Management of Internal Mammary Lymph Nodes.

Journal of breast imaging, 2020

Research

Breast cancer metastasis to intramammary lymph nodes.

AJR. American journal of roentgenology, 1986

Research

Sonographic appearance of normal intramammary lymph nodes.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 1988

Research

Intramammary lymph nodes.

Journal of clinical pathology, 1992

Guideline

Management of Intramammary Lymph Nodes in Breast Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.